Skip to main content
BELLUSCURA PLC logo

BELLUSCURA PLC — Investor Relations & Filings

Ticker · BELL ISIN · GB00BD3B8Z11 LEI · 213800BRJQZE56XBPW94 IL Manufacturing
Filings indexed 240 across all filing types
Latest filing 2023-06-29 Earnings Release
Country GB United Kingdom
Listing IL BELL

About BELLUSCURA PLC

https://belluscura.com/

Belluscura PLC is a medical device company specializing in the development and commercialization of advanced oxygen enrichment technologies. The company's primary focus is on manufacturing lightweight, portable oxygen concentrators (POCs) designed to improve the quality of life for individuals requiring supplemental oxygen therapy. Its product portfolio is headlined by the FDA-cleared X-PLOR® and the DISCOV-R™ models. These devices utilize proprietary, patented technologies such as ModulAir™ and an Airgonomical™ design to deliver high oxygen output in a compact form factor, offering an alternative to traditional, cumbersome oxygen tanks and promoting user mobility and independence.

Recent filings

Filing Released Lang Actions
Final Results for the year ended 31 December 2022
Earnings Release Classification · 95% confidence The document is an 'Earnings Release' (ER) because it is an initial announcement of financial results for the year ended 31 December 2022. It contains key financial highlights (revenue, loss, cash, inventory), operational highlights, and management commentary. Although it mentions that the full Annual Report has been posted to shareholders, the document itself provides the core financial data and highlights, fitting the definition of an Earnings Release rather than a mere Report Publication Announcement (RPA). FY 2022
2023-06-29 English
Share allotment; Director/PDMR Shareholding; Appt.
AGM Information Classification · 99% confidence The document is explicitly identified as an 'RNS Number' announcement from 'Belluscura PLC' dated '15 June 2023'. The content discusses several corporate actions: 'Confirmation of share allotment' following a Placing, Subscription, and Retail Offer; a 'Board appointment'; and 'Director / PDMR Shareholding' details. The presence of the RNS header, the nature of the announcements (share issuance, director dealings, board changes), and the explicit reference to UK MAR regulations strongly suggest this is a regulatory disclosure. Since it is a general regulatory announcement that covers multiple specific topics (capital change, director dealing, board change) and is distributed via the RNS system, the most appropriate general classification is Regulatory Filings (RNS). While it contains elements of Capital/Financing Update (CAP) and Director's Dealing (DIRS), the primary function here is the public disclosure via the regulatory news service.
2023-06-15 English
Result of General Meeting
AGM Information Classification · 99% confidence The document explicitly states 'Result of General Meeting' and provides a table detailing the voting results for resolutions passed at the General Meeting. This directly corresponds to the definition of 'Declaration of Voting Results & Voting Rights Announcements' (DVA). Although it is an RNS announcement, the specific content is about voting results, making DVA the most precise classification over the general RNS code.
2023-06-14 English
Result of Retail Offer
Share Issue/Capital Change Classification · 99% confidence The document starts with 'RNS Number' and is dated June 1, 2023. It explicitly states it contains 'INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF THE UK VERSION OF THE MARKET ABUSE REGULATION (UK MAR)'. The content announces the 'Result of Retail Offer' and details the capital raised (£3.1 million) through the issuance of new ordinary shares, conditional on shareholder approval at a General Meeting. This is a formal announcement of a significant corporate action (fundraising/share issuance) released via the London Stock Exchange's news service (RNS). While it relates to capital (CAP), the primary function here is the regulatory dissemination of this news via RNS, and the document structure strongly suggests a general regulatory announcement. Given the options, 'Regulatory Filings' (RNS) is the most appropriate general category for official, time-sensitive announcements distributed through the LSE's RNS system that don't fit a more specific financial report type (like 10-K or IR). However, since it details a share issue and fundraising, 'Capital/Financing Update' (CAP) is also highly relevant. Since the text is a formal announcement distributed via RNS, and the content is about capital raising, I will prioritize the specific corporate action type, CAP, as it is more descriptive than the general RNS fallback, although RNS is also plausible. Given the detailed nature of the fundraising announcement, CAP is the best fit.
2023-06-01 English
Proposed Board Appointment
Board/Management Information Classification · 99% confidence The document is an official announcement disseminated via RNS (RNS Number: 7364A) dated May 26, 2023. The content explicitly details the 'Proposed Board Appointment' of Robert (Bob) Sylvester Fary as an Executive Director, including his personal details, past directorships, and shareholdings related to the appointment. This directly aligns with the definition of 'Board/Management Information' (MANG), which covers announcements of changes in the company's board of directors or senior management.
2023-05-26 English
Retail Offer to raise up to £0.5m
Share Issue/Capital Change Classification · 99% confidence The document is an official announcement released via RNS (RNS Number : 6684A) on May 25, 2023. The content explicitly announces a 'Retail Offer to raise up to £0.5 million' through the issue of new ordinary shares. This clearly falls under the category of company fundraising and capital structure changes. The definition for Capital/Financing Update (CAP) covers 'Updates on company fundraising, financing activities, or capital structure changes.' Although it is an RNS announcement, the core subject matter is a specific financing event, making CAP a more precise classification than the general RNS fallback. The document is not merely announcing the publication of a report (RPA), but detailing the terms of a capital raise.
2023-05-25 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.